Christoph Wolfgang Zapf

Person

Marlborough, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 12,202,836
- Issue date Jan 21, 2025
- Pfizer Inc.
- John David Trzupek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof
- Patent number 12,049,471
- Issue date Jul 30, 2024
- NURIX THERAPEUTICS, INC.
- Arthur T. Sands
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-substituted piperidine compounds for Cbl-b inhibition, and use th...
- Patent number 11,951,133
- Issue date Apr 9, 2024
- NURIX THERAPEUTICS, INC.
- Arthur T. Sands
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 11,702,424
- Issue date Jul 18, 2023
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof
- Patent number 11,530,229
- Issue date Dec 20, 2022
- NURIX THERAPEUTICS, INC.
- Arthur T. Sands
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-substituted piperidine compounds for Cbl-b inhibition, and use th...
- Patent number 11,464,802
- Issue date Oct 11, 2022
- NURIX THERAPEUTICS, INC.
- Arthur T. Sands
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Substituted benzyl-triazole compounds for Cbl-b inhibition, and fur...
- Patent number 11,401,267
- Issue date Aug 2, 2022
- NURIX THERAPEUTICS, INC.
- Arthur T. Sands
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bruton's tyrosine kinase inhibitors
- Patent number 10,815,213
- Issue date Oct 27, 2020
- Pfizer Inc.
- John Robert Springer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 10,793,579
- Issue date Oct 6, 2020
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heteroaryl derivatives as CFTR potentiators
- Patent number 10,766,904
- Issue date Sep 8, 2020
- CYSTIC FIBROSIS FOUNDATION
- Joseph Walter Strohbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolopyrimidines as CFTR potentiators
- Patent number 10,494,374
- Issue date Dec 3, 2019
- CYSTIC FIBROSIS FOUNDATION
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heteroaryl derivatives as CFTR potentiators
- Patent number 10,377,762
- Issue date Aug 13, 2019
- CYSTIC FIBROSIS FOUNDATION
- Joseph Walter Strohbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 10,329,302
- Issue date Jun 25, 2019
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
- Patent number 10,316,018
- Issue date Jun 11, 2019
- Pfizer Inc.
- Katherine Lin Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolopyrimidines as CFTR potentiators
- Patent number 10,301,315
- Issue date May 28, 2019
- Cystic Fibrosis Foundation Therapeutics, Inc.
- Joseph Walter Strohbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bruton's tyrosine kinase inhibitors
- Patent number 10,266,513
- Issue date Apr 23, 2019
- Pfizer Inc.
- John Robert Springer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heteroaryl derivatives as CFTR potentiators
- Patent number 10,208,053
- Issue date Feb 19, 2019
- Cystic Fibrosis Foundation Therapeutics, Inc.
- Joseph Walter Strohbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
- Patent number 10,174,000
- Issue date Jan 8, 2019
- Pfizer Inc.
- Katherine Lin Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heteroaryl derivatives as CFTR potentiators
- Patent number 10,131,670
- Issue date Nov 20, 2018
- Cystic Fibrosis Foundation Therapeutics, Inc.
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 9,879,022
- Issue date Jan 30, 2018
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic-fused heteroaryl or aryl compounds
- Patent number 9,458,168
- Issue date Oct 4, 2016
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CYANO CYCLOBUTYL COMPOUNDS FOR CBL-B INHIBITION AND USES THEREOF
- Publication number 20240409555
- Publication date Dec 12, 2024
- Nurix Therapeutics, Inc.
- Arthur T. SANDS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE TH...
- Publication number 20240293458
- Publication date Sep 5, 2024
- Nurix Therapeutics, Inc.
- Arthur T. SANDS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bicyclic-Fused Heteroaryl or Aryl Compounds
- Publication number 20230339960
- Publication date Oct 26, 2023
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyrrolopyrimidines as CFTR Potentiators
- Publication number 20230250100
- Publication date Aug 10, 2023
- CYSTIC FIBROSIS FOUNDATION
- Joseph Walter Strohbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYANO CYCLOBUTYL COMPOUNDS FOR CBL-B INHIBITION AND USES THEREOF
- Publication number 20230212186
- Publication date Jul 6, 2023
- Nurix Therapeutics, Inc.
- Arthur T. SANDS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BENZYL-TRIAZOLE COMPOUNDS FOR CBL-B INHIBITION, AND FUR...
- Publication number 20230150991
- Publication date May 18, 2023
- Nurix Therapeutics, Inc.
- Arthur T. SANDS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION
- Publication number 20220387395
- Publication date Dec 8, 2022
- Nurix Therapeutics, Inc.
- Arthur T. SANDS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE TH...
- Publication number 20220378839
- Publication date Dec 1, 2022
- Nurix Therapeutics, Inc.
- Arthur T. SANDS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITORS OF CBL-B AND METHODS OF USE THEREOF
- Publication number 20220324835
- Publication date Oct 13, 2022
- Nurix Therapeutics, Inc.
- Paul A. BARSANTI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Pyrrolopyrimidines as CFTR Potentiators
- Publication number 20210171534
- Publication date Jun 10, 2021
- CYSTIC FIBROSIS FOUNDATION
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BENZYL-TRIAZOLE COMPOUNDS FOR CBL-B INHIBITION, AND FUR...
- Publication number 20210053961
- Publication date Feb 25, 2021
- Nurix Therapeutics, Inc.
- Arthur T. SANDS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYANO CYCLOBUTYL COMPOUNDS FOR CBL-B INHIBITION AND USES THEREOF
- Publication number 20210053986
- Publication date Feb 25, 2021
- Nurix Therapeutics, Inc.
- Arthur T. SANDS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bruton's Tyrosine Kinase Inhibitors
- Publication number 20210002251
- Publication date Jan 7, 2021
- Pfizer Inc.
- John Robert Springer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic-Fused Heteroaryl or Aryl Compounds
- Publication number 20200377511
- Publication date Dec 3, 2020
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE OF...
- Publication number 20200323904
- Publication date Oct 15, 2020
- Nurix Therapeutics, Inc.
- Arthur T. Sands
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RORC2 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20200039960
- Publication date Feb 6, 2020
- Pfizer Inc.
- Mark Edward Schnute
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRIMIDINES AS CFTR POTENTIATORS
- Publication number 20200017512
- Publication date Jan 16, 2020
- CYSTIC FIBROSIS FOUNDATION
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS
- Publication number 20190330219
- Publication date Oct 31, 2019
- CYSTIC FIBROSIS FOUNDATION
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic-Fused Heteroaryl or Aryl Compounds
- Publication number 20190270751
- Publication date Sep 5, 2019
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRIMIDINES AS CFTR POTENTIATORS
- Publication number 20190225621
- Publication date Jul 25, 2019
- CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC.
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bruton's Tyrosine Kinase Inhibitors
- Publication number 20190202798
- Publication date Jul 4, 2019
- Pfizer Inc.
- John Robert Springer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RORC2 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20190144429
- Publication date May 16, 2019
- Pfizer Inc.
- Mark Edward Schnute
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS
- Publication number 20190092750
- Publication date Mar 28, 2019
- Pfizer Inc.
- KATHERINE LIN LEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS
- Publication number 20190016727
- Publication date Jan 17, 2019
- Cystic Fibrosis Foundation Therapeutics, Inc.
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS
- Publication number 20190016728
- Publication date Jan 17, 2019
- Cystic Fibrosis Foundation Therapeutics, Inc.
- Joseph Walter Strohbach
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RORC2 INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20180282304
- Publication date Oct 4, 2018
- Pfizer Inc.
- Mark Edward Schnute
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS
- Publication number 20180244646
- Publication date Aug 30, 2018
- Pfizer Inc.
- KATHERINE LIN LEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS
- Publication number 20180170938
- Publication date Jun 21, 2018
- Cystic Fibrosis Foundation Therapeutics, Inc.
- Joseph Walter Strohbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRIMIDINES AS CFTR POTENTIATORS
- Publication number 20180141954
- Publication date May 24, 2018
- Cystic Fibrosis Foundation Therapeutics, Inc.
- Joseph Walter Strohbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bicyclic-Fused Heteroaryl or Aryl Compounds
- Publication number 20180127432
- Publication date May 10, 2018
- Pfizer Inc.
- John David Trzupek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Christoph Wolfgang Zapf

Person

Patents Grantslast 30 patents

Bicyclic-fused heteroaryl or aryl compounds

Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof

3-substituted piperidine compounds for Cbl-b inhibition, and use th...

Bicyclic-fused heteroaryl or aryl compounds

Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof

3-substituted piperidine compounds for Cbl-b inhibition, and use th...

Substituted benzyl-triazole compounds for Cbl-b inhibition, and fur...

Bruton's tyrosine kinase inhibitors

Bicyclic-fused heteroaryl or aryl compounds

Bicyclic heteroaryl derivatives as CFTR potentiators

Pyrrolopyrimidines as CFTR potentiators

Bicyclic heteroaryl derivatives as CFTR potentiators

Bicyclic-fused heteroaryl or aryl compounds

Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators

Pyrrolopyrimidines as CFTR potentiators

Bruton's tyrosine kinase inhibitors

Bicyclic heteroaryl derivatives as CFTR potentiators

Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators

Bicyclic heteroaryl derivatives as CFTR potentiators

Bicyclic-fused heteroaryl or aryl compounds

Bicyclic-fused heteroaryl or aryl compounds

Patents Applicationslast 30 patents

CYANO CYCLOBUTYL COMPOUNDS FOR CBL-B INHIBITION AND USES THEREOF

3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE TH...

Bicyclic-Fused Heteroaryl or Aryl Compounds

Pyrrolopyrimidines as CFTR Potentiators

CYANO CYCLOBUTYL COMPOUNDS FOR CBL-B INHIBITION AND USES THEREOF

SUBSTITUTED BENZYL-TRIAZOLE COMPOUNDS FOR CBL-B INHIBITION, AND FUR...

UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION

3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE TH...

INHIBITORS OF CBL-B AND METHODS OF USE THEREOF

Pyrrolopyrimidines as CFTR Potentiators

SUBSTITUTED BENZYL-TRIAZOLE COMPOUNDS FOR CBL-B INHIBITION, AND FUR...

CYANO CYCLOBUTYL COMPOUNDS FOR CBL-B INHIBITION AND USES THEREOF

Bruton's Tyrosine Kinase Inhibitors

Bicyclic-Fused Heteroaryl or Aryl Compounds

3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE OF...

RORC2 INHIBITORS AND METHODS OF USE THEREOF

PYRROLOPYRIMIDINES AS CFTR POTENTIATORS

BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS

Bicyclic-Fused Heteroaryl or Aryl Compounds

PYRROLOPYRIMIDINES AS CFTR POTENTIATORS

Bruton's Tyrosine Kinase Inhibitors

RORC2 INHIBITORS AND METHODS OF USE THEREOF

BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS

BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS

BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS

RORC2 INHIBITORS AND METHODS OF USE THEREOF

BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS

BICYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS

PYRROLOPYRIMIDINES AS CFTR POTENTIATORS

Bicyclic-Fused Heteroaryl or Aryl Compounds